Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Huntsville, Alabama


Purpose:

Effects of Teriparatide in Postmenopausal Women Previously Treated with Alendronate or Raloxifene.


Criteria:

Inclusion Criteria: - Postmenopausal women aged at least 50 years - A previous clinical diagnosis of osteoporosis - At high risk for fracture - Current therapy for at least 18 months prior to study entry with either raloxifene HCl or alendronate Na Exclusion Criteria: - History of metabolic bone disease other than osteoporosis - History of malignant neoplasm within the last 5 years except for superficial basal cell carcinoma or squamous cell carcinoma


NCT ID:

NCT00079924


Primary Contact:

Study Director
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company


Backup Contact:

N/A


Location Contact:

Huntsville, Alabama
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.